Anesthetic management for implantation of total artificial heart device: Case series [Total yapay kalp cihazi implantasyonunda anestezik yaklaşim: Olgu serisi]

Basit Öğe Kaydı
dc.contributor.authorSahutoğlu C.
dc.contributor.authorKaraca N.
dc.contributor.authorKocabaş S.
dc.contributor.authorAskar F.Z.
dc.contributor.authorErtugay S.
dc.contributor.authorEngin Ç.
dc.contributor.authorYağdı T.
dc.contributor.authorÖzbaran M.
dc.date.accessioned2019-10-26T21:18:35Z
dc.date.available2019-10-26T21:18:35Z
dc.date.issued2016
dc.departmentEge Üniversitesien_US
dc.description.abstractThe treatment of end-stage heart failure is heart transplant; however the majority of patients die due to deficiency of organ donation. Total artificial heart implantation made for the purpose of extending the life span and bridging to transplantation in patients with end-stage heart failure is a good option. We present our initial experiences in the anesthetic management of total artificial heart implantation cases performed in our institution. Five out of seven patients (46.8±8.4 years) were taken to surgery with inotropic support. Four patients were diagnosed as dilated cardiomyopathy. Three patients were subject to cardiac arrest during the preoperative period and mechanical ventilation was applied for one of these patients. Intraoperative ketamine, midazolam, fentanyl, rocuronium were used in doses of 192±89 mg, 8±3.5 mg, 335±157 µg and 192±43 mg, respectively. Fresh donor blood, fresh frozen plasma, thrombocyte and erythrocyte suspension requirements were 2.1±1.6 unit, 2± 1.8 unit, 0.43±0.5 unit and 0.6± 0.9 unit, respectively. At least one complication developed in all of the patients; four patients who had sepsis and renal failure died and; 3 patients who were not subject to this complication were discharged from the hospital. Total artificial heart implantation made for the purpose of bridging to transplantation for end-stage heart failure patients is a valuable option and its anaesthetic management is challenging. It is important that anesthesiologists have knowledge about the implanted device and the surgical procedure. © 2016 Nobelmedicus. All rights reserved.en_US
dc.identifier.endpage79en_US
dc.identifier.issn1305-2381
dc.identifier.issn1305-2381en_US
dc.identifier.issue2en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage75en_US
dc.identifier.urihttps://hdl.handle.net/11454/16534
dc.identifier.volume12en_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherNobelmedicusen_US
dc.relation.ispartofNobel Medicusen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAnesthetic agentsen_US
dc.subjectArtificial hearten_US
dc.subjectHeart-assist devicesen_US
dc.subjectPostoperative complicationsen_US
dc.subjectTreatment outcomeen_US
dc.titleAnesthetic management for implantation of total artificial heart device: Case series [Total yapay kalp cihazi implantasyonunda anestezik yaklaşim: Olgu serisi]en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu